Invasive assessment of cardiopulmonary hemodynamics may predict survival after transcatheter tricuspid edge-to-edge valve repair in patients with severe tricuspid regurgitation and symptomatic heart failure.
Elevated pulmonary artery systolic pressure was found to be associated with a worse prognosis in patients with heart failure with severe secondary mitral regurgitation.
The 6th WSPH Task Force on Hemodynamic Definitions and Clinical Classification recently proposed reducing the diagnostic mPAP threshold for pulmonary hypertension.
Echocardiographic surrogate for pulmonary arterial capacitance may independently predict mortality in pulmonary hypertension.
Implantation of the endovascular device Aria during right heart catheterization was found to favorably alter pulmonary circulation in patients with pulmonary arterial hypertension.
Metformin was found to be well-tolerated and safe for the treatment of pulmonary atrial hypertension.
The use of Ikari-curve left guiding catheters during balloon pulmonary angioplasty was found to allow access to branches not accessible with conventional guiding catheters.
Pulmonary vein sign was found to be easy to detect and to have higher sensitivity and specificity in chronic thromboembolic pulmonary hypertension compared with acute pulmonary embolism.
Oral combination therapy does not appear to help achieve or maintain low risk status in most treatment-naive patients with pulmonary arterial hypertension.
Nighttime nasal high flow therapy at 20 L/min reduced sympathetic drive in patients with precapillary pulmonary hypertension and obstructive sleep apnea.
